Skip NavigationSkip to Content

Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL)

  1. Author:
    Peeney, David [ORCID]
    Gurung, Sadeechya [ORCID]
    Rich, Joshua A
    Coates-Park, Sasha
    Liu, Yueqin
    Toor, Jack
    Jones,Jane
    Richie, Christopher T
    Jenkins, Lisa M [ORCID]
    Stetler-Stevenson, William G [ORCID]
  2. Author Address

    Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States., Center for Cancer Research Protein Expression Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States., Genetic Engineering and Viral Vector Core, Office of the Scientific Director, National Institute on Drug Abuse, Baltimore, Maryland 21224, United States., Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.,
    1. Year: 2024
    2. Date: Sep 05
    3. Epub Date: 2024 09 05
  1. Journal: Journal of Proteome Research
  2. Type of Article: Article
  1. Abstract:

    Proximity labeling (PL) has given researchers the tools to explore protein-protein interactions (PPIs) in living systems; however, most PL studies are performed on intracellular targets. We have adapted the original PL method to investigate PPIs within the extracellular compartment, which we term extracellular PL (ePL). To demonstrate the utility of this modified technique, we investigated the interactome of the matrisome protein TIMP2. TIMPs are a family of multifunctional proteins that were initially defined by their ability to inhibit metalloproteinases, the major mediators of extracellular matrix (ECM) turnover. TIMP2 exhibits broad expression and is often abundant in both normal and diseased tissues. Understanding the functional transformation of matrisome regulators, such as TIMP2, during disease progression is essential for the development of ECM-targeted therapeutics. Using dual orientation fusion proteins of TIMP2 with BioID2/TurboID, we describe the TIMP2 proximal interactome (MassIVE MSV000095637). We also illustrate how the TIMP2 interactome changes in the presence of different stimuli, in different cell types, in unique culture conditions (2D vs 3D), and with different reaction kinetics, demonstrating the power of this technique versus classical PPI methods. We propose that screening of matrisome targets in disease models using ePL will reveal new therapeutic targets for further comprehensive studies.

    See More

External Sources

  1. DOI: 10.1021/acs.jproteome.4c00606
  2. PMID: 39238192

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel